244 related articles for article (PubMed ID: 15056143)
1. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index.
Rhee JS; Matthews BA; Neuburg M; Smith TL; Burzynski M; Nattinger AB
Dermatol Surg; 2004 Apr; 30(4 Pt 1):525-9. PubMed ID: 15056143
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and sun-protective behavior in patients with skin cancer.
Rhee JS; Matthews BA; Neuburg M; Smith TL; Burzynski M; Nattinger AB
Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):141-6. PubMed ID: 14967741
[TBL] [Abstract][Full Text] [Related]
3. Quality of life assessment in nonmelanoma cervicofacial skin cancer.
Rhee JS; Loberiza FR; Matthews BA; Neuburg M; Smith TL; Burzynski M
Laryngoscope; 2003 Feb; 113(2):215-20. PubMed ID: 12567071
[TBL] [Abstract][Full Text] [Related]
4. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
Chen T; Bertenthal D; Sahay A; Sen S; Chren MM
Arch Dermatol; 2007 Nov; 143(11):1386-92. PubMed ID: 18025362
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.
Lee EH; Klassen AF; Nehal KS; Cano SJ; Waters J; Pusic AL
J Am Acad Dermatol; 2013 Aug; 69(2):e59-67. PubMed ID: 23102770
[TBL] [Abstract][Full Text] [Related]
6. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.
Chren MM; Sahay AP; Bertenthal DS; Sen S; Landefeld CS
J Invest Dermatol; 2007 Jun; 127(6):1351-7. PubMed ID: 17301830
[TBL] [Abstract][Full Text] [Related]
7. The skin cancer index: clinical responsiveness and predictors of quality of life.
Rhee JS; Matthews BA; Neuburg M; Logan BR; Burzynski M; Nattinger AB
Laryngoscope; 2007 Mar; 117(3):399-405. PubMed ID: 17334300
[TBL] [Abstract][Full Text] [Related]
8. Creation of a quality of life instrument for nonmelanoma skin cancer patients.
Rhee JS; Matthews BA; Neuburg M; Burzynski M; Nattinger AB
Laryngoscope; 2005 Jul; 115(7):1178-85. PubMed ID: 15995503
[TBL] [Abstract][Full Text] [Related]
9. Quality of life issues in nonmetastatic skin cancer.
Burdon-Jones D; Thomas P; Baker R
Br J Dermatol; 2010 Jan; 162(1):147-51. PubMed ID: 19796177
[TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
11. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.
Basra MK; Sue-Ho R; Finlay AY
Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244
[TBL] [Abstract][Full Text] [Related]
12. Changes in quality of life over 1 year in patients with head and neck cancer.
Ronis DL; Duffy SA; Fowler KE; Khan MJ; Terrell JE
Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):241-8. PubMed ID: 18347247
[TBL] [Abstract][Full Text] [Related]
13. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
Schinstine M; Goldman GD
J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
[TBL] [Abstract][Full Text] [Related]
14. Nonmelanoma skin cancer: disease-specific quality-of-life concerns and distress.
Radiotis G; Roberts N; Czajkowska Z; Khanna M; Körner A
Oncol Nurs Forum; 2014 Jan; 41(1):57-65. PubMed ID: 24368239
[TBL] [Abstract][Full Text] [Related]
15. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
16. Deterioration in quality-of-life of late (10-year) survivors of head and neck cancer.
Mehanna HM; Morton RP
Clin Otolaryngol; 2006 Jun; 31(3):204-11. PubMed ID: 16759240
[TBL] [Abstract][Full Text] [Related]
17. Delayed treatment and continued growth of nonmelanoma skin cancer.
Alam M; Goldberg LH; Silapunt S; Gardner ES; Strom SS; Rademaker AW; Margolis DJ
J Am Acad Dermatol; 2011 May; 64(5):839-48. PubMed ID: 21055843
[TBL] [Abstract][Full Text] [Related]
18. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
19. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
[No Abstract] [Full Text] [Related]
20. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
Lennox RD; Leahy MJ
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
